Next Generation IV Infusion Pumps Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Next Generation IV Infusion Pumps Market: By Product Type (Syringe infusion pumps, Large Volumetric Infusion Pumps, Implantable Infusion Systems, Patient Controlled Analgesia Pumps, Disposable Elastomeric Infusion Systems, Others), By Application (Analgesia, Oncology, Hematology, Diabetes, Neonatology, Neurological Disorders, Gastroenterology, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centres) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Next-Generation IV Infusion Pumps Market size is to grow at a significant rate during the forecast period 2022-2028. Next generation IV infusion pumps market growth driven by the innovation of newer pumps with modern technologies. Majority of the market players are developing newer technologies such as wearable insulin pumps, smartphone connected insulin pumps, and implantable insulin pumps among others, which are anticipated to fuel the market. Moreover, advantages with next generation pumps such as ease of using, patient safety, and accurate dosage also expected to bolster the market. Furthermore, acquisitions and mergers, product approvals, and product launchings are the strategies followed by market players for increasing their revenue share in next generation IV infusion pumps market. For instance, in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration. Next generation IV infusion pumps are the combination of intuitive user interface, simplicity, and state of art information technology. Next generation IV infusion pumps are inclined with the advanced pumping systems to improve the patient safety and work efficiency. A user interface is designed for next generation IV infusion pumps to diminish the programming errors to save the time and reduce in pump interactions. Next generation IV infusion pumps are frequently adopted by healthcare professionals to improve patient safety. The other advantages with next generation IV infusion pumps include affordability, flexibility, and ease of use, scalability, targeted delivering, and safer operability among others. in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration.

Next Generation IV Infusion Pumps Market

MARKET SUMMARY
-
x
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– X%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Next Generation IV Infusion Pumps Market Analysis

  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global Variable Air Volume (VAV) Systems market
  • In January 2017, Ivenix, Inc. demonstrated advanced infusion pump interoperability at HIMSS 17, the system exchanges data with EMR and Alarm Management Systems to improve the patient care, quality, safety, and outcomes.
  • Ivenix received FDA approval in June 2019 for an infusion system that is designed to make infusions safer and decrease the recurring difficulties that come with infusion pumps.
Market Leaders
  • Braun Melsungen AG (Germany)
  • Johnson & Johnson Services, inc. (U.S.)
  • Hoffmann-la Roche Ltd. (Switzerland)
  • Baxter International, Inc. (U.S.)
  • Zyno medical (U.S.)
  • Smiths Medical (U.S.)
  • Ivenix, Inc (U.S.)
Next Generation IV Infusion Pumps Market

Drivers and Restraints

Increase in the prevalence and incidence of diabetes, malnutrition, neurological disorders, cancers, technological advancements in the devices, and ease of usage with more safety are anticipated to fuel the next generation IV infusion pumps market. Moreover, government support for start-ups, favorable regulatory policies, and expansion in production capacity are anticipated to boost the next generation IV infusion pumps market over the forecast period. However, product recalls, medicine dispensing errors, lack of skilled professionals, and lack of standard guidelines for product usage are anticipated to hinder the growth of next generation IV infusion pumps market over the forecast years.


Next Generation IV Infusion Pumps Market Regional Analysis

North America dominates the market

North America next generation IV infusion pumps market is growing due to advances in healthcare infrastructure, presence of key market players and skilled professionals in the region. Europe next generation IV infusion pumps market is projected to grow at a significant rate owing to adoption of newer technologies, rise in R&D activities for the innovation of newer products, and collaboration between companies for distribution and development of newer products. Asia Pacificnext generation IV infusion pumps market expected to garner significant share due to increase in prevalence of chronic diseases such as diabetes, cancer, and neurological disorders, developing healthcare infrastructure, and increase in awareness about next generation IV infusion pumps among key stakeholders in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Next Generation IV Infusion Pumps Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Braun Melsungen AG (Germany)
  • Johnson & Johnson Services, inc. (U.S.)
  • Hoffmann-la Roche Ltd. (Switzerland)
  • Baxter International, Inc. (U.S.)
  • Zyno medical (U.S.)
  • Smiths Medical (U.S.)
  • Ivenix, Inc (U.S.)
  • Hospira (Pfizer, Inc.) (U.S.)
  • Becton, Dickinson, and Company (U.S.)
  • Terumo Corporation (Japan)

Description

Next-Generation IV Infusion Pumps Market size is to grow at a significant rate during the forecast period 2022-2028. Next generation IV infusion pumps market growth driven by the innovation of newer pumps with modern technologies. Majority of the market players are developing newer technologies such as wearable insulin pumps, smartphone connected insulin pumps, and implantable insulin pumps among others, which are anticipated to fuel the market. Moreover, advantages with next generation pumps such as ease of using, patient safety, and accurate dosage also expected to bolster the market. Furthermore, acquisitions and mergers, product approvals, and product launchings are the strategies followed by market players for increasing their revenue share in next generation IV infusion pumps market. For instance, in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration. Next generation IV infusion pumps are the combination of intuitive user interface, simplicity, and state of art information technology. Next generation IV infusion pumps are inclined with the advanced pumping systems to improve the patient safety and work efficiency. A user interface is designed for next generation IV infusion pumps to diminish the programming errors to save the time and reduce in pump interactions. Next generation IV infusion pumps are frequently adopted by healthcare professionals to improve patient safety. The other advantages with next generation IV infusion pumps include affordability, flexibility, and ease of use, scalability, targeted delivering, and safer operability among others. in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX